Arcturus Therapeutics Holdings Inc. ·
ARCT 8-K 2026-07-02
Arcturus Therapeutics Holdings Inc. (ARCT) 8-K dated 2026-07-02 — accession 0001193805-26-000910. This URL is the filing, not the ARCT hub.
Arcturus Therapeutics Holdings Inc. (ARCT) is a biotechnology company listed on US.
Arcturus Therapeutics Holdings Inc. filed a 8-K on 2026-07-02. Accession 0001193805-26-000910.
Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Not investment advice. The ARCT SEC hub lists recent forms. The stock page is the research view.